Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lapidot Group is an Israeli healthcare company focused on the import, distribution, marketing, sales, and servicing of medical products, pharmaceuticals, diagnostics, and wellness offerings. Rather than operating like a drug-development biotech, the group acts as a commercialization and market-access partner for international healthcare companies in Israel across medical devices, hospital products, diagnostics, optics, and consumer health. The company also operates healthcare service activities, including a GMP/GDP-enabled compounding center and the Lapidot Arad Dialysis Center. Its business appears to be centered on commercial-stage products and service delivery rather than an internal R&D pipeline of novel therapeutics. Lapidot Group positions itself as one of Israel’s leading healthcare companies and emphasizes deep local distribution, regulatory, logistics, and customer-service capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lapidot Group.